The pharmacological and therapeutic actions of penicillamine are very largely explained by its ability to chelate metal ions and take part in oxidation-reduction reactions, sulphydryl-disulphide interchange, and nucleophilic addition. Effects of penicillamine on particular enzymes are explained by its chemical properties. Possible interactions with amino acids, tissue proteins, food constituents, and intermediates in the metabolism and biosynthesis ofsulphur-containing amino acids are discussed.
Introduction
Penicillamine is a trifunctional amino acid in which a carboxyl group and an amino group are attached to one carbon atom and a sulphydryl and two methyl groups to a second. It differs from valine in having a sulphydryl group. It differs from cysteine in that two hydrogen atoms attached to the second carbon atom of cysteine are ieplaced in penicillamine by methyl groups. The SH group in penicillamine is therefore much more sterically hindered than the corresponding group in cysteine. D-penicillamine is usually or always more active pharmacologically, while the L-isomer occurs 'naturally'. The three functional groups in penicillamine undergo characteristic chemical reactions. These include acid-base equilibria, nucleophilic addition and displacement, combination with various metals, oxidation, and free radical transformations induced by ultraviolet and gamma radiation and by free radicals such as hydrogen and hydroxyl radicals.
The three functional groups in penicillamine differ enormously in their ability to participate in these reactions. Factors that influence such differences include the pH of the reaction medium, ionization (as specified by pKa values), and the respective nucleophilic and electrophilic reactivities, which are influenced in turn by steric and electronic factors as well as by hydrogen-bonding and hydrophobic interactions. The influence of these factors on the reactivity of penicillamine in vitro and in vivo will be discussed primarily in terms of organic reaction mechanisms. An attempt will be made to explain the behaviour 'This paper was not read at the Symposium and role of penicillamine in terms of its known chemical properties in normal and diseased states, including Wilson's disease, metal poisoning, cystinosis, cystinuria, and rheumatoid arthritis and related connective tissue abnormalities (Perings & Junge 1975) . 1 also outline possible interactions of penicillamine with diet components, including carbohydrates and proteins.
Syntheses andPhysicochemical Properties
The various ways of synthesizing D-penicillamine are reviewed by Weigert et al. (1975) . The extensively studied physical-chemical properties of D-and L-penicillamine and their metal complexes are detailed in the following references, which provide excellent access to the literature: Budzinski & Box 1971 , Cockerill et al. 1974 , Cothern et al. 1976 , Copeland 1970 , Doornbos & Feitsma 1967 , Freeman et al. 1976 , Friedman 1973 , Lal et al. 1975 , Letter & Jordan 1975 , Purdie et al. 1973 , Rao et al. 1973 , Rabenstein & Fairhurst 1975 , Rosenfield & Parthasarathy 1975 , Snow et al. 1975 , Thich et al. 1974 , Vasiliev et al. 1973 , Vasiliev et al. 1974 , Wu & Kuntz 1975 Metal Binding Penicillamine is used therapeutically to increase excretion of copper by patients who suffer from Wilson's disease (hepatolenticular degeneration) (Friedman 1973) . This disease is caused by inherited error in copper metabolism and is characterized by an accumulation of copper in the body. Schizophrenic patients are also reported to suffer from hypercupraemia. Penicillamine is also used as an antidote in mercury and lead poisoning (MacGregor & Clarkson 1974 , Lilis & Fischbein 1976 ). The chemical basis for these therapeutic uses of penicillamine is that it forms stable, soluble chelates with these metals over a wide pH range that includes physiological pH. The bound metal ions are then removed from the circulatory system by urinary excretion.
From a detailed study of the interaction of D-penicillamine and triethylenetetramine (trien) with copper ions in vitro and in vivo, Sarkar, Sass-Kortsat, Clarke, Laurie & Wei (p 13) concluded that: (l) Trien competes more effectively than penicillamine, for copper bound to albumin and to whole human serum; (2) penicillamine, but not trien, can enter the liver and mobilize copper there; (3) both compounds mobilize copper in the kidney, so both help to remove copper by urinary excretion. These authors state that their results support conclusions of Walshe (1973) that D-penicillamine and trien act on different pools of copper in patients with Wilson's disease, but they do not agree that trien removes copper from tissue while penicil-lamine binds plasma copper, thus rendering it available for filtration from the glomerulus.
In their critical review of mercurial toxicity, MacGregor & Clarkson (1974) note that penicillamine appears to be a better antidote for mercury poisoning than BAL (2,3-dimercaptopropanol) Both D-penicillamine and N-acetyl-DL-penicillamine are orally effective antidotes to mercuric chloride. The acetyl derivative is also effective against mercury vapour intoxication.
Administration of penicillamine increases urinary excretion of lead in hyperactive children with raised blood lead levels (Darrow & Schroeder 1974) . Ercoli (1968) discovered that penicillamine reduces the toxic but not therapeutic effects of drugs that contain arsenic and antimony and are used in treating parasitic diseases caused by schistosomes, leishmania, and trypanosomes. This discovery led to the preparation of several penicillamine chelates, including those of oxyphenarsine (mepharsen) and sodium potassium antimony tartrate (tartar emetic). In each case, chelation enhances the chemotherapeutic-toxicological index.
Penicillamine Cogeners and Derivatives
Studies by Sweetman et al. (1971) and by Field et al. (1973) revealed that all three functional groups of COOH, NH2, and SH of D-penicillamine are needed to lower rat skin tensile strength, a measure of anti-arthritic effectiveness. These authors synthesized various congeners of penicillamine and demonstrated that the following three compounds (Fig 1) were effective in lowering skin tensile strength: the zinc chelate of penicillamine, 2,2,5,5-tetramethyl-4-thiazolidine carboxylic acid hydrochloride, and DL-2-(1-mercaptocyclopentyl) glycine hydrochloride. Both skeletal modification and latentiation were used to design penicillamine derivatives that compare favourably with penicillamine in therapeutic activity toward rheumatoid arthritis. In attempts to make new internal standards for amino acid analysis and to elucidate the principles that govern the binding of mercuric and methylmercuric chlorides to keratin proteins, we have synthesized several model amino acid derivatives, including derivatives of cysteine and penicillamine derivatives with modified chelating sites (Fig 2) . 1970 , Friedman & Noma 1970 , Wu et al. 1971 , Cavins & Friedman 1970 , Friedman, Harrison et al. 1973 , Masri et al. 1972 , Friedman & Waiss 1972 , Friedman, Noma & Masri 1973 , Friedman & Masri 1974 , Masri & Friedman 1974 ). Studies carried out in collaboration with Dr A N Booth of this laboratory (Tables 1 and 2) show that the cysteine derivatives show a low order of toxicity. Since one of the compounds (2-PEC) was shown to be an excellent chelating agent for mercuric and methylmercuric chloride in vitro (Fish & Friedman 1972) , and since S-pyridylethyl wool showed increased binding capacity for mercuric and methylmercuric chlorides and for several other toxic and industrial metal salts, such synthetic cysteine and penicillamine derivatives may be useful as therapeutic agents in metal poisoning.
In tests of possible value in mercury poisoning, young adult male Sprague-Dawley rats were given HgC12 by intraperitoneal injection (3 mg/ kg body weight) as described by Aposhian & Aposhian (1959) . Five rats were given 100 mg of 2-PEC by stomach tube 2 h before mercury injection, at the time of injection, and at 4 h afterwards. Nine of 10 rats given only HgC12 died within five days. Unfortunately, the rats given the 2-PEC treatment also died, 3 out of 5 before those given only HgC12. Since other rats given only 2-PEC survived, the combination of 2-PEC and mercury appears responsible for the early deaths.
Perhaps the next step should be to investigate the toxicity of the Hg-2-PEC complex by stomach tube or by intraperitoneal injection. Such tests Evidently 2-PEC is not suitable for oral treatment of mercury poisoning under the conditions described. We were, however, surprised to find that administration of 2-PEC to rats appears to increase the toxicity of mercuric chloride. The reason for this is not clear. One possible explanation is that 2-PEC chelates the mercury in vivo and then transports it across the blood-brain barrier more rapidly than mercuric chloride passes by itself, and more rapidly than it is excreted. The toxic effect is then manifested when SH-compounds in the brain (for example) competitively remove the mercury salt from the 2-PEC.
Although in fact 2-PEC appears actually to increase the toxicity of HgC12 to rats, tests of the therapeutic use of penicillamine derivatives and analogues such as shown in Tables 2 and 3 Table 2 Toxicity of three cysteine derivatives: S-1-(4-pyridylethyl)- Table 3 Mouse LD,, values for two organic phosphate compounds Approximate LD50 values have been determined in young adult male Swiss-Webster mice. Feed was withheld overnight from those mice receiving the compounds by oral tube. For the intraperitoneal (IP) injections feed was not withheld The oral LD,, is about 2100 mg/kg body wt for both compounds; the intraperitoneal LD,, is between 600 and 1000 mg/kg body wt for both compounds Fig 3 would still be worthwhile. These preliminary results are reported here in the hope that they will stimulate additional studies in this area. A primary objective of such studies should be to demonstrate the statistical significance of the cited effects.
Thiazolidine Formation Pyridoxal-5-phosphate is a coenzyme of amino acid decarboxylases and transaminases. Extensive studies with enzyme models have been conducted to discover the catalytic mechanisms mediated by this and related compounds. Penicillamine readily participates in reactions with carbonyl compounds, including pyridoxal (Friedman & Sigel 1966 , Abbott & Martell 1970 , Friedman 1973 ).
The equilibrium constants for forming thiazolidine derivatives from pyridoxal phosphate and aminothiols (equation 1) are high, ranging from 106M for cysteine to 107 M for penicillamine.
(thiazolidine) (H20)
Penicillamine displaces many of the common amino acids from Schiff's bases to form stable thiazolidine derivatives. Thus, Schonbeck et al. (1975) measured rates of equilibration of cysteine and penicillamine with the Schiff base N6-(Ppyridoxylidene)-e-aminocaproic acid to form the thiazolidine derivatives N2S3-(P-pyridooxylidene)cysteine and N2S3-(P-pyridooxylidene)-penicillamine (equation 2) as models for transaldimination and resolution of pyridoxal-P enzymes by aminothiols. They found that the thiazolidine formed from penicillamine is about 12 times more stable than the thiazolidine formed from cysteine. These -results imply that penicillamine can exert some of its biological effects by forming relatively stable thiazolidine derivatives with the pyridoxal moiety of pyridoxal-phosphate-requiring enzymes and thus alter or interfere with their normal catalytic activity. The kinetic analysis also suggests that penicillamine can successfully compete with cysteine in thiazolidine formation in vivo. Kc Schiff base of6-aminocaproic acid+penicillamine = 6-aminocaproic acid + thiazolidine derivative ofpenicillamine (2) The mechanism of inhibition of collagen formation by penicillamine is discussed in detail in the paper by Nimni (page 65) and will therefore be considered only briefly here.
The time-course of penicillamine inhibition of collagen formation was examined by Ruiz-Torres (1974) , who concludes that D-penicillamine exerts its influence on collagen biosynthesis indirectly by increasing the pool of tropocollagen which depresses the rate of collagen-biosynthesis. The complex physiological consequences of collagen crosslink-inhibition by D-penicillamine are examined in detail by Rucker et al. (1977) . Their results support the view that penicillaminealdehyde interaction to form thiazolidine derivatives is the primary mechanism. Decreased crosslinking causes, in chickens, bone fragility, dissecting aneurysms, internal hemorrhage, and death. Otsuka & Mori (1976) suggest that the anti-rheumatoid effect of penicillamine may be due to its inhibition of lysosomal enzyme release in connective tissue membranes. Similarly, Abe et al. (1973) found that rats treated with either DL-or D-penicillamine grew more slowly and showed marked changes in liver phospholipids. The phospholipid effect could be reversed by pyridoxine.
Studies by
Thiazolidine formation in vivo appears to depend on which isomer is given. Thus, Tomono et al. (1973) found that administration of penicillamine to rats lowers the activities of the pyridoxal-requiring enzymes glutamate decarboxylase in the brain and ornithine amino-transferase in the small intestine, but increases the activities of these enzymes in the liver. DL-penicillamineinduced changes were eliminated when pyridoxine was given simultaneously. This result may mean that pyridoxine (vitamin B6) successfully competes with pyridoxal for penicillamine in vivo or is just quite changed to pyridoxal and replaces pyridoxal bound by penicillamine.
In contrast to DL-penicillamine, D-penicillamine did not affect ornithine aminotransferase activity in any of the organs tested (liver, small intestine, kidney); therefore changes in pyridoxal enzyme activities caused by DL-penicillamine administration appear to be caused by the Lisomer. Siegmund et al. (1968) were unable to confirm the reported (Kuchinskas & du Vigneaud 1957) inhibition of aspartic transaminase by Lpenicillamine. If we accept that neither D-nor L-penicillamine inhibits the enzyme, and since the rate of thiazolidine formation between either penicillamine isomer and pyridoxal phosphate would be expected to be the same, the observed anti-vitamin-B6 activity of L-penicillamine cannot be rationalized in terms of differences in rates of formation of the iespective thiaiolidines. The authors suggest that the anti-vitamin-B6 action of penicillamines may result not from thiazolidine formation but from interaction with other keto acids that, participate in transamination ). In contrast, both enantiomers of penicillamine inhibit alanine transaminase ). Studies by Nagasawa et al. (1975) reveal that intraperitoneally injected D-penicillamine combines with ethanol-derived acetaldehyde to form 3,5,5-trimethyl-D-thiazolidine-4-carboxylic acid (TTCA, Fig 4) .
These authors suggest that D-penicillamine may be valuable for counteracting ethanol intoxication which appears mainly due to acetaldyhyde, so that penicillamine should be investigated also as a possible protective agent against overdoses of other aldehydes, such as chloral hydrate, paraldehyde, and formaldehyde (possibly derived from methanol), as well as two toxic compounds derived from vinyl chloride, chloracetaldehyde and chlorethylene oxide. Each of these compounds is expected, like acetaldehyde, to react readily with penicillamine to form a possibly less toxic derivative (see also Cedarbaum & Rubin 1976) .
A related possibility may also merit study. Bjorksten (1977) has suggested that formaldehyde may crosslink DNA molecules and that the resulting impairment may be an important part of aging. Anti-crosslinking agents may therefore perhaps be useful for increasing the lifespan of animals, including human beings. If this conjecture is correct, penicillamine, which can combine with formaldehyde to form thiazolidine, may help to preserve youthful vigour by inhibiting crosslinking by formaldehyde. In spite of the fact that penicillamine has less reducing power than some ofthe other biologically important thiols, penicillamine is an effective biochemical reducing agent. Some possibilities of pharmacological interest will be outlined.
Interactions with Quinones
Quinones undergo two kinds of reaction with thiols (Friedman 1973 (Friedman , 1977 . Two molecules of a thiol may participate in oxidation-reduction with a quinone to form the corresponding hydro- quinone and disulphide. Alternatively, thiol anions may add to the conjugated system of a quinone to form a substituted hydroquinone. Excess quinone in the reaction mixture usually oxidizes the monosubstituted hydroquinone to the corresponding quinone derivative, which may then participate in another nucleophilic addition, and so on. In addition, the amino and SH groups of aminothiols can both condense with a quinone to give cyclized products. These various reactions are important in biochemistry and pharmacology.
To obtain evidence relevant to the controversial use of D-penicillamine in schizophrenia, Mattke & Adler (1971) evaluated the therapeutic effectiveness of D-penicillamine on clinical symptoms. They noted a statistically significant improvement in patients treated with the drug and concluded that their data are consistent with the view that D-penicillamine exerts an anti-schizophrenic effect at the molecular level by combining with essential copper, thus blocking copper enzymes needed for catecholamine synthesis. This inhibition also leads to suppression of melanogenesis. A relevant study by L0vstad (1976) , designed to establish the role of penicillamine in schizo- phrenia and melanin biosynthesis, revealed that penicillamine appears to prevent biosynthesis of the intermediate dopachrome by reducing an active oxidation product of DOPA in an oneelectron reduction to an unidentified free radical. Reduced penicillamine was itself oxidized to penicillamine disulphide. Biosynthesis of melanin through the tyrosinase-catalyzed oxidation of DOPA recommenced as soon as all the added penicillamine was consumed in the reduction.
The described reduction may be one mechanism by which penicillamine affects the skin pigmentation of schizophrenic patients treated with penicillamine and prevents formation of adrenochrome from adrenaline.
Other reactions inhibiting melanin biosynthesis are also possible. For example, cysteine reacts with dopaquinone in feather papillae of embryonic New Hampshire chicks to form 5-S-cysteinyldopa (Misuraca et al. 1969 , Rorsman et al. 1973 ). This compound is further oxidized to phaeomelanin. I believe that penicillamine may interact similarly with the conjugated system of dopaquinone to give an analogous derivative (5-S-penicillaminyl DOPA) and thus block melanin biosynthesis at the dopaquinone state (Fig 4) .
An investigation of the relative reactivities of several thiols and aminothiols and the nature of products formed in their reactions with adrenochrome revealed that penicillamine reacted only 1/30 as rapidly as cysteine or homocysteine and formed melanin rather than the expected reduction products or adducts.
The interaction of oxidized catechol derivatives, such as oxidized adrenaline, with thiols has been studied extensively because of its possible significance in melanin formation and other biological processes. Much of the chemical information is ambiguous (Mattok 1967) .
Finally, reference is made to discussion by Chauffe et al. (1975) of reduction pathways of quinone moieties in melanin and to a description by Blois (1974) of interrelationships of melanin and adrenaline (epinephrine) biosynthesis via dopaquinone.
Disulphide Cleavage and Sulphydryl-disulphide Interchange Penicillamine depolymerizes high-molecularweight macroglobulins found in sera of patients with neoplastic disease, Waldenstr6m's macroglobulinemia (Bloch et al. 1960 , Schneider 1967 . Depolymerization probably takes place by sulphydryl-disulphide interchange, leading to the formation of penicillamine-protein mixed disulphides with lower molecular weight.
In vitro studies by Raab & Morth (1974) show that D-penicillamine and N-acetylcysteine increased the solubility of dermal proteins, including collagen, and peptides. The authors suggest that the solubilizing effect may be due to cleavage of disulphide bonds by both penicillamine and acetylcysteine in analogy with the observed depolymerizing effect of such compounds on pathological macroglobulins. Gerber (1972) suggests that penicillamine and gold thiomalate exert their beneficial effects in rheumatoid arthritis by suppressing gammaglobulin aggregation. This result, in the case of penicillamine, could arise from cleavage of disulphide bonds in the protein to form mixed penicillamine-gammaglobulin disulphides.
The mucolytic and protein-cleaving activity of such compounds as N-acetylcysteine and penicillamine is presumably due to their ability to break -S-S-bonds to form mixed disulphides of lower molecular weight and to their ability to initiate sulphydryl-disulphide interchanges, possibly converting interchain disulphide bonds of proteins present in mucus to intrachain bonds. Planas-Bohne (1973) showed that D-penicillamine forms a mixed disulphide with serum proteins. Since cystine, cysteine, and the SH blocking agent N-ethylmaleimide all inhibit protein binding of D-penicillamine, the author suggests that protein SH groups, which are present in 4 to 6 x 10-4 molar concentration in serum proteins, participate in disulphide bond formation. The participation of albumin disulphide bonds, however, cannot be excluded. It is also noteworthy that the mixed cysteine-penicillamine disulphide appears to react more slowly with SH groups (k=0.001 minm-) than the mixed disulphide derived from albumin and penicillamine (k =0.035 min-1). This comparison suggests that penicillamine will be liberated more rapidly and thus be more readily available for therapeutic activity from the mixed protein-penicillamine disulphide via sulphydryl-disulphide interchange than from the smaller mixed disulphide.
In a study of the therapeutic mechanisms of penicillamine, Raab & Morth (1974) evaluated its effects on the alkaline phosphatases from calf intestine, human serum, and rat kidney. In each case, a strong inhibitory effect was noted. Cobalt ions partly reduced the inhibition. Zinc ions overcame it completely. Two possible mechanisms are cited to account for this inhibitory effect. Penicillamine may take part in SH-SS interchange with the enzyme or it may chelate zinc ions essential for activity. The disulphide interchange results in blocking an essential SH group or in changing a necessary configuration. Both mechanisms may operate. These results also imply that patients receiving penicillamine may very likely show altered serum enzyme profiles.
In related studies, Raab & Gmeiner (1976) showed that D-penicillamine in high concentrations (above 6.7 mmol/l) inhibited glucose-6phosphate dehydrogenase (G-6-P) in purified enzyme preparations and in human heemolysates. The inhibitory influence may again be due to formation of a penicillamine-enzyme disulphide in which essential enzyme SH groups are blocked. Low concentrations of D-penicillamine partially offset the inhibitory action of zinc ions on G-6-P activity. The protection was not shown by higher concentrations of D-penicillamine. Evidently, at low levels, penicillamine preferentially chelates zinc ions, thus preventing their inhibitory influence on enzyme activity. However, at higher levels, D-penicillamine not only chelates zinc and other metal ions but begins to exert an inhibitory effect of its own. Although D-penicillamine concentrations used in these in vitro studies were high, they approach concentration levels sometimes used in therapy (about 6 g/day). Thus, the cited effects may operate in vivo. These studies also imply that D-penicillamine may affect keratinization in skin by participating in sulphydryl-disulphide interchange reactions with the SH and S-S bonds of keratin proteins. Sulphur compounds have a key role in keratinization and are also important structural elements of hair and skin (Matoltsy 1976 ).
Cystinosis is a rare congenital disease of childhood in which deposits of cystine are found throughout the body (Kroll & Lichte 1973) . The associated clinical manifestations of the disease include cystinuria and are referred to as the Fanconi syndrome. In an attempt to discover the biochemical causes and manifestations of cystinosis, Patrick (1962 Patrick ( , 1965 observed that (1) GSH concentration and the reduction of cystine to cysteine by cystine reductase and by glutathionecysteine transhydrogenase are normal in cystinotic liver; and (2) sulphydryl-dependent enzymes (glucose-6-phosphate dehydrogenase, hexokinase, succinate dehydrogenase, alcohol dehydrogenase, aminolevulinate dehydrase, and coenzyme A) are specifically inactivated by cystine in cystinotic liver. Patrick suggests that impairment of sulphydryl-dependent enzyme systems in cystinotic livers and other tissues probably results from reaction between cystine and the SH-enzyme to form an inactive mixed enzyme-cysteine disulphide. It should be pointed out, however, that since the cystine is deposited as a solid in various tissues, the interchange would have to occur under heterogeneous conditions. Cystine is, of course, very poorly soluble, but I expect that the small amount in solution can react, setting up a dynamic equilibrium based on Le Chatelier's principle, so that more solid dissolves as formation of the soluble disulphide progresses. Similarly, various solubilizing agents could transport it freely, e.g. as mixed disulphides.
From these facts, one would expect that administration of SH compounds such as penicillamine should decrease the cystine deposits of patients with cystinosis and cystinuria. This expectation was, indeed, realized. Crawhall & Thompson (1965) found that oral administration of D-penicillamine lowered plasma cystine levels of patients with cystinuria. The decrease accompanied formation of cysteine-penicillamine disulphide (see also Ekberg et al. 1974 ). (1970) discovered that (1) cystinosis is a derangement of lysosomal disulphide metabolism or transport and (2) exposure of cultured fibroblasts from cystinotic, but not from normal, individuals to L-cysteine-D-penicil-lamine disulphide induces vacuolation, so that (3) this vacuolation furnishes a histological criterion that may be useful for diagnosis. This criterion may, of course, not be a primary etiologic mechanism.
Schulman & Bradley
Relative Reactivities Amino and SH groups in amino-mercapto acids such as penicillamine may react concurrently with a large number of structurally different compounds.
We Friedman et al. 1965 , Cavins & Friedman 1968 , Friedman & Noma 1970 , Snow et al. 1975 investigated factors that govern nucleophilic reactivities of functional groups in amino-mercapto acids and related compounds with a,,-unsaturated compounds such as acrylonitrile, methyl acrylate, vinylpyridine, and dehydroalanine. The ratio of reaction rates of the SH to the NH2 groups in compounds in which SH groups are attached to primary carbon atoms, as in cysteine and glutathione, vary from 300 to 1300. The SH groups in penicillamine and ,B-mercaptoisoleucine (methylethylcysteine) were only about seven times as reactive as their amino groups. Steric factors hindering access of the vinyl-type reagents to the SH groups appear to be responsible for the lower reactivity of the SH group in penicillamine, ,B-mercaptoisoleucine, and their corresponding N-acetyl derivatives. Sulphydryl groups in these compounds are attached to tertiary carbon atoms, whereas the corresponding groups in cysteine or glutathione are attached more accessibly to primary carbon atoms.
In related studies, Snow et al. (1975) noted that the SH group of penicillamine reacted only 1/40 as rapidly as the SH group of N-acetyldehydrolanine. Boyd (1968) found that cyanide ions react only one-sixteenth as fast with the mixed disulphide of penicillamine and cysteine (PSSCy) as with cystine (CySSCy). The slower rates are further evidence of steric hindrance by the two methyl groups attached to the carbon atom of penicillamine.
A study of sulphite ion cleavage of unsymmetrical disulphides including penicillaminecysteamine disulphide by Van Rensburg & Swanepoel (1967) revealed that steric factors are mainly responsible for the observed direction of the displacement and that the pH of the medium and electronic effects have only minor influence on the products.
What are some implications of these observations with regard to pharmacological activity? First, the fact that the SH group of penicillamine is much less reactive than SH groups in other biological thiols such as cysteine and glutathione has a limiting effect on the number of reactions in which penicillamine can take part during its passage through an animal. The most probable reactions are fast reactions such as metal chelation and thiazolidine ring formation in which both the SH and NH groups participate. Slower reactions such as formation of, mixed disulphides with proteins can also take place. These appear to be useful in some diseased states in which penicillamine depolymerizes high molecular weight
proteins. It appears that penicillamine would be less effective for this purpose if it were highly reactive so that it would be more easily tied up with normal tissue proteins.
Second, the fact that penicillamine has the lowest reducing power of aminothiols tested (Okumura et al. 1974) implies that it will not be less readily inactivated than other biological thiols in vivo by oxidation to the disulphide or higher oxidation states by oxidizing agents, which may include not only catalase and peroxidase but also methionine sulphoxide present in some diets (Walker et al. 1975) , as well as various intermediates in the biosynthesis and metabolism of sulphur amino acids. These intermediates, which could include hypotaurine, cysteine sulphenic acid, cysteine sulphinic acid, and cystine monoxide, would be expected to interact readily with penicillamine (Allison 1976 , Baker 1976 , Hayes 1976 , Kochakian & Marcais 1974 , possibly as suggested in Fig 5. Some of the pharmacological and therapeutic properties of penicillamine may very well result from such reactions, which, however, remain to be demonstrated. Snow et al. (1975) measured oxidation rates of SH groups of penicillamine, cysteine, and glutathione to the SS form by dimethyl sulphoxide and other sulphoxides including methionine sulphoxide. Penicillamine was found to be 1/4 and 1/10 as reactive as glutathione and cysteine, respectively. As in other cases, two factors may contribute to the lower reactivity of penicillamine; greater steric hindrance and the consequent lower reducing power of its SH group. The amino group of penicillamine may catalyse reduction of the sulphoxide by participating in hydrogen bonding interactions with S=O groups.
Besides possibly reacting with methionine sulphoxide and aldehydic food constituents such as glucose, our kinetic studies imply that penicillamine can also interact with other natural sulphoxides. These include S-propenyl-L-cysteine sulphoxide, S-allyl cysteine sulphoxide, and cycloalin, and allyl propyl disulphide present in onions and garlic (Augusti 1974 , Augusti & Mathew 1974 , Schwimmer & Friedman 1972 , Carson & Boggs 1966 , lenthionine, present in mushrooms (Kyoden et al. 1971) , cystathionine sulphoxide, present in animal tissues (Datko et al. 1975) , and ergothioneine, present in Neurospora crassa (Ishikawa et al. 1974 ).
In conclusion, although my objective has been to offer a unified presentation of the molecular reactions of penicillamine based on its chemical properties, this treatment has been only partly successful, primarily because of the lack of specificity in penicillamine action. The compound participates in too many interactions which are quite general, affecting several enzyme and organ systems, to be easily understood. Nevertheless, I believe that an understanding of its specific biochemical actions offers great hope for more effective use in several diseased states such as metal poisoning, schizophrenia, arthritis, and cystinosis, and may be used to guide the design of improved drugs.
